Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Gregory P AdamsLouis M Weiner

Abstract

Radiolabeled single-chain Fv (sFv) molecules display highly specific tumor retention in the severe combined immunodeficient (SCID) mouse model; however, the absolute quantity of sFv retained in the tumors is diminished by the rapid renal elimination resulting from the small size of the sFv molecules (Mr 27,000) and by dissociation of the monovalent sFv from tumor-associated antigen. We previously reported significant improvement in tumor retention without a loss of targeting specificity on converting monovalent sFv into divalent [(sFv')2] dimers, linked by a disulfide bond between COOH-terminal cysteinyl peptides engineered into the sFv'. However, our data for enhanced dimer localization in tumors could not distinguish between the contributions of enhanced avidity and increased systemic retention associated with the larger size of 54 kDa [(sFv')2] dimers relative to 27-kDa sFv. In this investigation, we have compared tumor targeting of divalent anti-c-erbB-2/HER2/neu 741F8-1 (sFv')2 homodimers with monovalent 741F8/26-10 (sFv')2 heterodimers (Mr 54,000) and 741F8 sFv monomers (741F8 sFv has binding specificity for erbB-2/HER2/neu and 26-10 sFv specificity for digoxin and related cardiac glycosides). These studies allowed us to ...Continue Reading

References

Jan 23, 1979·Biochemistry·J A Reynolds
Jul 18, 1990·Journal of the National Cancer Institute·D ColcherJ Schlom
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J S HustonR Crea
Oct 21, 1988·Science·R E BirdM Whitlow
Feb 1, 1996·Immunotechnology : an International Journal of Immunological Engineering·A M WuJ E Shively
May 1, 1995·Immunotechnology : an International Journal of Immunological Engineering·R SchierL M Weiner

❮ Previous
Next ❯

Citations

May 8, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Florian KampmeierTheo Thepen
Mar 1, 2007·Bioconjugate Chemistry·Derek W Bartlett, Mark E Davis
Jul 25, 2009·The Journal of Biological Chemistry·Roland StorkRoland E Kontermann
Sep 27, 2006·Cancer Biotherapy & Radiopharmaceuticals·Huguette Albrecht, Sally J DeNardo
Jul 14, 2007·Cancer Biotherapy & Radiopharmaceuticals·Ali SheikholvaezinTorgny Stigbrand
May 5, 2009·Cancer Biotherapy & Radiopharmaceuticals·Stephen I Rudnick, Gregory P Adams
Aug 17, 2010·Cancer Biotherapy & Radiopharmaceuticals·Rozbeh JafariBirgitta E Sundström
Oct 30, 2008·Protein Engineering, Design & Selection : PEDS·Jeffrey V LeytonAnna M Wu
Sep 7, 2007·Journal of Virology·Kosei HasegawaKah-Whye Peng
Sep 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott M Knowles, Anna M Wu
Sep 23, 2008·Expert Opinion on Pharmacotherapy·Peng H Tan, Amrit S Lota
Apr 15, 2008·Expert Opinion on Biological Therapy·P H TanP J Friend
Jul 22, 2006·Expert Opinion on Biological Therapy·D K Wilkins, A Mayer
Mar 31, 2010·Seminars in Nuclear Medicine·Smitha Reddy, Matthew K Robinson
Oct 13, 2015·Biochemistry and Biophysics Reports·Xiaolei WangW Barry Edwards
Apr 18, 2014·Molecular Pharmaceutics·Haiming LuoWeibo Cai
Nov 17, 2009·Experimental Cell Research·Stefanie PfaffenDario Neri
Jun 1, 2007·Clinical Oncology : a Journal of the Royal College of Radiologists·J L J Dearling, R B Pedley
May 1, 2007·Biomolecular Engineering·David Filpula
Dec 13, 2006·ChemMedChem·Jascha-N RybakDario Neri
Feb 27, 2007·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Aparna S JoshiSanford H Barsky
Dec 13, 2007·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Aug 12, 2008·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Sergey M Deyev, Ekaterina N Lebedenko
Mar 20, 2014·Biotechnology Journal·Angela R JonesEric V Shusta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.